NCT04655144View on ClinicalTrials.gov

Dexamethasone for Post Uterine Artery Embolization Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

January 25, 2021

Primary Completion Date

December 4, 2024

Study Completion Date

December 4, 2024

Conditions
Leiomyoma
Interventions
DRUG

Dexamethasone

Dexamethasone delivered to the uterine arterial bed, prior to embolization.

DRUG

Saline

Saline delivered to the uterine arterial bed, prior to embolization.

Trial Locations (1)

33136

Sylvester Comprehensive Cancer Center, Miami

All Listed Sponsors
lead

University of Miami

OTHER

NCT04655144 - Dexamethasone for Post Uterine Artery Embolization Pain | Biotech Hunter | Biotech Hunter